Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim for Prevention of Neutropenia in Breast Cancer Chemotherapy
NCT00771433Phase 2Completed
- Sponsor
- Centre François Baclesse
- Start
- Oct 2007
- Primary completion
- May 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in neutropenia, febrile neutropenia (FN), sponsored by Centre François Baclesse. Started Oct 2007; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropeniafebrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00771433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771433.